OTCMKTS:ACUS

Acusphere Stock Forecast, Price & News

$0.05

+0.01 (+32.35 %)

(As of 05/17/2021 11:38 AM ET)

Add

Compare

Today's Range

$0.04

▼

$0.05

50-Day Range

$0.03

▼

$0.05

52-Week Range

$0.01

▼

$0.06

Volume14,030 shs

Average Volume19,977 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

Beta-0.25

30 days | 90 days | 365 days | Advanced Chart

Receive ACUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Acusphere and its competitors with MarketBeat's FREE daily newsletter.

About Acusphere

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

Curis Inc
January 29, 2021 | bloomberg.com

Acusphere Inc
January 16, 2021 | cnbc.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:ACUS

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.acusphere.com

Phone617-648-8800

EmployeesN/A

Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

2006th out of 2,032 stocks

Pharmaceutical Preparations Industry

765th out of 768 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Acusphere.

0.0 Community Rank

Outperform Votes
Acusphere has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Acusphere has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Acusphere and other stocks. Vote “Outperform” if you believe ACUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACUS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Acusphere does not currently pay a dividend.
Dividend Growth
Acusphere does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Acusphere insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.60% of the stock of Acusphere is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Acusphere (OTCMKTS:ACUS) Frequently Asked Questions

What stocks does MarketBeat like better than Acusphere?

Wall Street analysts have given Acusphere a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acusphere wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Acusphere's key executives?

Acusphere's management team includes the following people:

Dr. William I. Ramage D.Phil, Chief Devel. Officer (Age 67, Pay $225.09k)

Who are some of Acusphere's key competitors?

Some companies that are related to Acusphere include Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), China Dongsheng International (CDSG), China Health Industries (CHHE), Diadexus (DDXSQ), ERBA Diagnostics (ERBA), GelStat (GSAC), Global Future City (FTCY), Greenwich LifeSciences (GLSI), Harbor Diversified (HRBR), Imagenetix (IAGX), Interpharm (IPAH) and Inyx (IYXI).
View all of ACUS's competitors.

What is Acusphere's stock symbol?

Acusphere trades on the OTCMKTS under the ticker symbol "ACUS."

How do I buy shares of Acusphere?

Shares of ACUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acusphere's stock price today?

One share of ACUS stock can currently be purchased for approximately $0.05.

What is Acusphere's official website?

The official website for Acusphere is www.acusphere.com.

Where are Acusphere's headquarters?

Acusphere is headquartered at 500 ARSENAL ST, WATERTOWN MA, 02472.

How can I contact Acusphere?

Acusphere's mailing address is 500 ARSENAL ST, WATERTOWN MA, 02472. The company can be reached via phone at 617-648-8800 or via email at [email protected]

This page was last updated on 5/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Acusphere Stock Forecast, Price & News

Adding

Adding

Adding Acusphere, Inc.

About Acusphere

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth